We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AIM
1
ARK Investment Management
Florida
$98.1M -$19.8M -217,119 -19%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$72.1M +$66.5K +729 +0.1%
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$62.8M +$52.8M +578,504 New
NAMA
4
Nikko Asset Management Americas
New York
$47.5M +$1.82M +19,964 +5%
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$47.5M +$1.82M +19,964 +5%
BlackRock
6
BlackRock
New York
$36.1M +$143K +1,569 +0.5%
FP
7
Flagship Pioneering
Massachusetts
$31.9M
ABG
8
Ally Bridge Group
New York
$28.7M +$24.1M +264,250 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$22.2M +$103K +1,128 +0.6%
SB
10
Samsara BioCapital
California
$21.8M +$7.13M +78,125 +55%
OFM
11
Omega Fund Management
Massachusetts
$17M +$14.3M +156,250 New
O
12
OrbiMed
New York
$17M +$14.3M +156,250 New
EC
13
EcoR1 Capital
California
$10.8M +$9.13M +100,000 New
AG
14
Artal Group
Luxembourg
$8.14M +$2.6M +28,450 +61%
JP Morgan Chase
15
JP Morgan Chase
New York
$7.98M +$28.7K +314 +0.4%
State Street
16
State Street
Massachusetts
$7.89M -$8.87M -97,254 -57%
BBA
17
Baker Bros. Advisors
New York
$7.49M
Geode Capital Management
18
Geode Capital Management
Massachusetts
$6.4M +$85.7K +939 +2%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$5.48M -$527K -5,772 -10%
Northern Trust
20
Northern Trust
Illinois
$4.9M -$91.7K -1,005 -2%
PCM
21
Portolan Capital Management
Massachusetts
$4.14M -$629K -6,894 -15%
Millennium Management
22
Millennium Management
New York
$4.13M +$2.09M +22,924 +152%
Charles Schwab
23
Charles Schwab
California
$2.64M -$1.46K -16 -0.1%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$2.54M +$388K +4,251 +22%
Two Sigma Advisers
25
Two Sigma Advisers
New York
$2.5M +$444K +4,870 +27%